Background: Childhood cancer survivors commonly experience long-term treatment effects that impair physical function. Access to in-person physical fitness assessments is often limited by geographic, logistical, and resource constraints. Virtually supervised physical fitness assessments may offer a feasible alternative; however, evidence in this population remains limited. Methods: This study evaluated the feasibility of delivering virtually supervised physical fitness assessments via videoconference for children and adolescents aged 5–18 years following completion of cancer treatment. Assessments evaluated lower-body strength (30 s sit-to-stand), upper-body strength (30 s push-up), mobility (timed up-and-go), balance (single-leg balance), aerobic endurance (two-minute step), and flexibility (sit-and-reach). Pre-defined feasibility benchmarks included recruitment (≥15 participants within three months), assessment completion (≥85% of participants completing all six assessments), individual assessment completion (≥90% of planned assessments completed), technique fidelity (≥85% of assessments performed with correct technique), session duration (≥90% of sessions completed in ≤30 min), safety (no adverse events), and participant satisfaction (qualitative feedback). Results: Twenty-nine participants were enrolled, with 28 completing the virtual assessments. The sample (61% male) had a mean age of 9.8 ± 3.7 years (range 5–16), with acute lymphoblastic leukaemia the most common diagnosis (46%). Recruitment exceeded benchmarks (23 participants within three months). Assessment completion was 92.9% (26/28), individual assessment completion was 98.8% (166/168), and technique fidelity was 90.9%, with the lowest fidelity for push-ups (73.1%). Most sessions were completed within 30 min (92.9%; median 19.5 min, range 15–33). No adverse events occurred. Feedback indicated high satisfaction, highlighting convenience, engagement, and practicality. Conclusions: Virtually supervised physical fitness assessments were feasible, safe, and acceptable for childhood cancer survivors. These findings provide initial feasibility evidence to support further validation and implementation research before broader clinical application.
O’Malley et al. (Mon,) studied this question.